Vitamin D receptor gene variants and serum vitamin D in Childhood Autism Spectrum Disorder

doi:10.21203/rs.3.rs-1736074/v1

Download PDF

Research Article

Vitamin D receptor gene variants and serum vitamin D in Childhood Autism Spectrum Disorder

https://doi.org/10.21203/rs.3.rs-1736074/v1

This work is licensed under a CC BY 4.0 License

You are reading this latest preprint version

OBJECTIVE: This study aimed to examine the correlation between polymorphisms in vitamin D receptor (VDR) gene and serum vitamin D, and to determine their role in predicting childhood Autism Spectrum Disorder (ASD).

METHODS: A total of 269 children with ASD and 320 age- and gender- matched healthy controls were recruited from the Chinese Han population. Their serum 25(OH) vitamin D was measured using competitive chemiluminescent immunoassays. The TaqMan probe approach was applied to analyze the common VDR SNPs rs731236 (Taq1), rs11568820 (Cdx2), rs1544410 (BsmI), rs2228570 (FokI) and rs7975232 (API). Both linear and logistic regressions were applied in data analysis.

RESULTS: Children with ASD had significantly lower levels of serum vitamin D and a significantly higher rate of vitamin D deficiency (< 20 ng/ml) compared to healthy controls (67.7% vs 34.1%). All these examined VDR SNPs were not correlated with serum vitamin D concentrations or vitamin D deficiency. Logistic regression analysis revealed that rs731236 and serum vitamin D were associated with childhood ASD. The area under the receiver operating characteristic (ROC) curve was 0.7285 for serum vitamin D. Children with both T/C genotype of rs731236 and vitamin D deficiency had a higher risk of being diagnosed with ASD.

CONCLUSION: All examined common VDR SNPs are not correlated with serum vitamin D concentrations or vitamin D deficiency. The combination of T/C phenotype of rs731236 and vitamin D deficiency are associated with a higher risk of childhood ASD. Vitamin D is a promising target in the prevention and treatment of this disease.

Autism Spectrum Disorder (ASD)

SNP

vitamin D

receptor

deficiency

Autism spectrum disorder (ASD) is a complex neurodevelopmental disability with repetitive behaviors and deficits in social interactions and language skills. Multiple genetic and environmental risk factors have been implicated in the development of the disease [1–3]. The high prevalence and comorbidities of this disease bring huge health and economic burdens worldwide [4–6].

Vitamin D has been considered as one of the environmental factors related to the development of ASD. In addition to its role in bone health, vitamin D has important functions in cell differentiation, immune modulation and neural development [7–9]. Lower serum vitamin D has been observed in children with ASD from different countries [10–15]. Vitamin D deficiency during pregnancy or early childhood has been associated with an increased risk of ASD [15–17]. Animal studies reported autism-relevant behaviors and brain abnormalities in offspring exposed to vitamin D deficiency during gestation [18, 19]. On the other hand, vitamin D supplementation has been shown to improve symptoms in children with ASD [12].

Vitamin D functions to modulate gene transcriptions which are mainly mediated by its receptor (VDR). The VDR gene is located on chromosome 12q13 with nine exons and eight introns [20]. Five common SNPs rs731236 (Taq1), rs11568820 (Cdx2), rs1544410 (BsmI), rs2228570 (FokI) and rs7975232 (API) have been identified at different regions of the VDR gene. These SNPs have been shown to impact the structure of VDR proteins, transcriptional activity and functions [21–24]. Some of these SNPs have been associated with the risk of childhood ASD [25, 26], though others reported negative findings [27–29].

The correlation between serum vitamin D levels and SNPs in the VDR gene is still inconclusive. Earlier studies reported an association between rs10735810 in the VDR gene and serum vitamin D levels in multiple sclerosis patients [30] and severe vitamin D deficiency in patients who underwent angiography due to suspected coronary artery disease [31]. A later study found a correlation between rs2228570 (FokI) and serum vitamin D in children with ASD [25] and in multiple sclerosis patients [32]. In contrast, Cieslinska et al reported that VDR SNPs rs2228570, rs731236, rs1544410, and rs7975232 were not associated with vitamin D concentration in children with ASD [33] and in children who were obese/overweight [34].

The objective of this case control study was to first examine the common VDR SNPs (rs731236 (Taq1), rs11568820 (Cdx2), rs1544410 (BsmI) and rs2228570 (FokI)) and serum vitamin D in children with ASD and their healthy controls from the Chinese Han population. We then determined the correlation between the SNPs and serum vitamin D, and their role in predicting childhood ASD.

This case-control study was conducted from March 2016 to December 2018. A total of 269 children diagnosed with ASD were recruited from local Hospitals in the Xiaoshan District of Zhejiang province. Diagnoses of all cases were based on DSM-V criteria by two neuro-pediatricians. The exclusion criteria were: children with other psychiatric disorders, chronic medical comorbid conditions, those who received calcium and/or vitamin D therapy in the past 12 months, or were on a treatment known to affect serum vitamin D levels. A total of 320 age- and gender-matched healthy controls were selected from both a preschool and a primary school in the same district. This study was approved by the Medical Ethics Committee of Zhejiang Xiaoshan Hospital. Informed consent was obtained from parents or guardians of all children.

Fasting blood samples were collected from both autistic children and healthy controls. After centrifugation, aliquots of the serum samples were immediately stored at -80 ^oC before the assay. Serum 25(OH)D concentration were measured on the E601 modular (Siemens Healthineers, Beijing, China). All the tests in this study were performed in our clinical laboratory in Xiaoshan Hospital. Tests were performed in triplicate for each sample and the averaged values were used in the data analyses. TaqMan probe approach was applied to determine the genotypes of SNPs in DNA extracted from blood cells. TaqMan probes were designed and synthesized by Applied Biosystems (Beijing, China). Real-time PCR was conducted following the manufacturer’s protocol as described previously [26, 35].

Statistical analysis

Categorical variables were expressed as percentages and their differences were examined by χ² tests. Continuous variables are presented as mean (SD) and examined by Student’s t-tests. Associations between the VDR SNPs and serum 25(OH) D levels were analyzed using linear regression models. Logistic regression was applied to determine the relationship between the SNPs and vitamin D deficiency, between SNPs and childhood ASD, and between serum vitamin D and ASD. Logistic regression models were used to calculate the area under the ROC curve to estimate the role of serum vitamin D in predicting the risk of childhood ASD. Two-sided P-values less than 0.05 were considered to be significant. All statistical analyses were carried out using SAS 9.4 software (SAS Institute Inc., Cary, NC).

Both children with ASD and healthy controls had similar ages and comparable gender ratio (Table 1). The average concentration of serum vitamin D was 18.3 ± 6.3 ng/ml for children with ASD and 23.5 ± 7.4 ng/ml for healthy control (P < 0.0001). Among children with ASD, 182 (67.7%) of them had a vitamin D deficiency (< 20 ng/ml), and 68 (25.3%) had a vitamin D insufficiency (20 ~ 29.9 ng/ml). Healthy controls had a significantly lower proportion of vitamin D deficiency (34.1%), but a similar proportion of insufficiency.

Table 1

Characteristics of children with ASD and healthy controls
Variable	Overall (n = 589)	Case (n = 269)	Control (n = 320)	P
Age (years)
Mean	6.3 ± 3.8	6.5 ± 3.9	6.1 ± 2.7	0.2456
Median (range)	5 (2–14)	5 (2–14)	5 (3–14)
Gender
Male	479 (81.3)	222 (82.5)	257 (80.3)	0.4453
Female	110 (18.7)	47 (17.4)	63 (19.7)
Vitamin D (ng/ml)
Mean	21.4 ± 7.4	18.3 ± 6.3	23.5 ± 7.4	< 0.0001
Median (range)	20.1 (4.2–57.7)	17.6 (4.2–40.4)	21.9 (9.3–57.7)
< 20 or Deficiency	291 (49.4)	182 (67.7)	109 (34.1)	< 0.0001
20 ~ 29.9	232 (39.4)	68 (25.3)	164 (25.3)
≥ 30	66 (11.2)	19 (7.1)	47 (14.7)

Our data showed that there was no significant correlation between the examined VDR SNPs and serum vitamin D concentrations in in children with ASD, or healthy controls, or all children combined (Table 2). Genotypes of all SNPs examined were not significantly correlated with the vitamin D deficiency in children with ASD, or healthy controls, or all of the children (Table 3).

Table 2

Correlation between VDR SNPs and serum vitamin D concentrations
SNPs	Genotype	Vitamin D (ng/ml)	P
Children with ASD
rs731236	T/T	18.5 ± 6.1	0.2669
	T/C	17.3 ± 7.1
rs1568820	G/G	18 ± 5.9	0.5338
	G/A	18.4 ± 5.8
	A/A	18.4 ± 7.1
rs2228570	T/T	18 ± 5.9	0.9128
	T/C	18.4 ± 5.8
	C/C	18.4 ± 7.1
rs154440	G/G	18.5 ± 6	0.0691
	G/A	16.7 ± 7.6
Healthy controls
rs731236	T/T	23.6 ± 7.6	0.7800
	T/C	23.2 ± 6.2
rs1568820	G/G	23 ± 7.6	0.6857
	G/A	23.8 ± 7.5
	A/A	23.8 ± 7
rs2228570	T/T	22.1 ± 6.3	0.2743
	T/C	24 ± 7.5
	C/C	24 ± 8.3
rs1544410	G/G	23.6 ± 7.6	0.8158
	G/A	23.1 ± 5.8
All children
rs731236	T/T	21.4 ± 7.4	0.1104
	T/C	19.9 ± 7.3
rs1568820	G/G	20.9 ± 7.4	0.7105
	G/A	21.3 ± 7.5
	A/A	21.6 ± 7.2
rs2228570	T/T	22 ± 6.4	0.1350
	T/C	24 ± 7.4
	C/C	24 ± 8.3
rs1544410	G/G	21.4 ± 7.4	0.1544
	G/A	20 ± 7.5

Table 3

Correlation between VDR SNPs and vitamin D deficiency.

SNPs	Genotype	Non-deficient	Deficient	OR (95% CI)	P
Children with ASD
rs731236	T/T	138 (65.7)	72 (34.3)
	T/C	29 (74.4)	10 (25.6)	1.48 (0.68–3.21)	0.3197
rs1568820	G/G	59 (66.3)	30 (33.7)
	G/A	78 (70.3)	33 (29.7)	1.24 (0.68–2.26)	0.2639
	A/A	30 (62.5)	18 (37.5)	0.82 (0.39–1.71)	0.3628
rs2228570	T/T	45 (69.2)	20 (30.8)	1
	T/C	82 (68.3)	38 (31.7)	0.99 (0.51–1.9)	0.6437
	C/C	39 (62.9)	23 (37.1)	0.75 (0.36–1.58)	0.3767
rs1544410	G/G	142 (65.4)	75 (34.6)
	G/A	25 (80.7)	6 (19.4)	2.19 (0.86–5.57)	0.1008
Healthy controls
rs731236	T/T	96 (34)	186 (66)
	T/C	11 (35.5)	20 (64.5)	1.07 (0.49–2.32)	0.8714
rs1568820	G/G	36 (35)	67 (65.1)
	G/A	55 (35)	102 (65)	1 (0.6–1.69)	0.65
	A/A	16 (30.2)	37 (69.8)	0.81 (0.4–1.64)	0.5037
rs2228570	T/T	31 (41.9)	43 (58.1)
	T/C	49 (30.3)	113 (69.8)	0.6 (0.34–1.06)	0.1288
	C/C	27 (35.1)	50 (64.9)	0.75 (0.39–1.45)	0.901
Rs1544410	G/G	93 (33.8)	182 (66.2)
	G/A	14 (36.8)	24 (63.2)	1.14 (0.56–2.31)	0.7127
All children
rs731236	T/T	234 (47.6)	258 (52.4)	1
	T/C	40 (57.1)	30 (42.9)	1.47 (0.88–2.43)	0.1388
rs1568820	G/G	95 (49.5)	97 (50.5)	1
	G/A	133 (49.6)	135 (50.4)	1.01 (0.7–1.47)	0.553
	A/A	46 (45.5)	55 (54.5)	0.84 (0.51–1.36)	0.4012
rs2228570	T/T	78 (56.1)	61 (43.9)	1
	T/C	129 (45.7)	153 (54.3)	0.66 (0.44-1)	0.1636
	C/C	66 (47.5)	73 (52.5)	0.71 (0.44–1.13)	0.4772
rs1544410	G/G	235 (47.8)	257 (52.2)	1
	G/A	39 (56.5)	30 (43.5)	1.14 (0.5–2.62)	0.7524

The correlation between the VDR SNPs and childhood ASD was analyzed by logistic regression. Both genotype and allele frequency of s731236 was significantly associated with childhood ASD. There was no significant association between other SNPs and childhood ASD (Supplemental data Table S1).

Results of logistic regression models indicated that an increased serum vitamin D concentration was significantly associated with a decreased risk of childhood ASD (Odd ratio (OR) = 0.87, 95% confidence interval (CI): 0.85–0.90) (Table 4). The area under the ROC curve for serum vitamin D was 0.7285 (95% CI: 0.6889–0.7338, P < 0.0001)) in predicting the risk of childhood ASD (Fig. 1). At the optimal vitamin D cutoff point (19.0 ng/ml) the sensitivity and specificity were 71.5% and 69.6%, respectively. In combination with VDR, SNPs didn’t improve the predicting performance (data not shown). Our data also showed that vitamin D deficiency was significantly associated with the increased risk of ASD (OR = 3.92, 95% CI: 2.76–5.58, P < 0.0001) (Table 5). Children with both vitamin D deficiency and the T/C genotype rs731236 had a higher risk of ASD compared to children with vitamin D deficiency alone, or with the T/C genotype alone, or with genotype A/A and no vitamin D deficiency (Table 4).

Table 4

Predictor roles of serum vitamin D and other markers in childhood ASD
Variable		OR (95% CI)	P
Serum vitamin D
Continuous (ng/ml)		0.88 (0.85–0.91)	< .0001
Deficiency	No	1
	Yes	3.92 (2.76–5.58)	< 0.001
rs731236 + vitamin D deficiency
T/C	Yes	1
T/C	No	0.57 (0.28–1.17)	0.0017
T/T	Yes	0.19 (0.07–0.53)	0.039
T/T	No	0.15 (0.07–0.31)	< .0001

Vitamin D has been implicated as an important environmental factor related to the development of ASD. This study examined the correlation between VDR SNPs and serum vitamin D in children from the Chinese Han population, and then determined their roles in predicting childhood ASD. Our data showed that children with ASD had significantly lower serum levels of vitamin D and a higher rate of vitamin D deficiency. The examined SNPs were not associated with serum vitamin D levels or vitamin D deficiency. SNP rs731236, or low serum vitamin D, or vitamin deficiency was correlated with the risk of childhood ASD. Children with both T/C genotype of rs731236 and vitamin D deficiency had a higher risk of ASD.

This study indicated that there was no correlation between all examined VDR SNPs and serum D levels or vitamin D deficiency in children with ASD, or healthy controls, or all children. Notably, up to 269 children with ASD and 320 healthy controls from the Chinese Han population were included in this study. Similar to this finding, a previous study examined rs731236, rs7975232, rs1544410, rs2228570, and rs11568820 as well as serum vitamin D in 106 overweight/obese and 86 healthy (control) Chinese Han children, from a nearby district. No association was observed between these VDR SNPs and serum vitamin D [34]. A Poland study reported no statistical significant differences according to VDR SNPs (rs731236, rs7975232, rs1544410 and rs2228570) and serum vitamin D concentrations in children with ASD [33]. Conversely, Coskun et al discovered that the T/T genotype of rs2228570 was significantly associated with an increased risk of childhood ASD and with higher serum vitamin D in Turkish children with ASD [25]. An Italian study revealed that rs2228570, but not rs1544410, rs731236 and rs7975232, was significantly correlated with serum vitamin D in multiple sclerosis patients [32]. A Mexican study evaluated the correlation between the vitamin D deficiency and genetic variants on VDR and the vitamin D binding protein (GC) genes in 689 unrelated postmenopausal women. Their results showed that the SNPs rs4516035 in VDR and rs2282679 in GC were associated with vitamin D deficiency [36]. All these findings suggest that the association between VDR SNPs and serum vitamin D is region and race/ethnicity specific.

Our study confirmed that children with T/C genotype, or C allele of the SNP rs731236 had a significantly increased risk of childhood ASD, whereas other SNPs examined in this study were not associated with the risk of childhood ASD [26]. The Poland study enrolled 108 children with ASD, and 196 non-ASD children. Their result indicated that rs2228570 and rs7975232, but not rs1544410 and rs731236, of the VDR gene were correlated with ASD [33]. Another Turkish study revealed that rs731236, rs2228570, and rs1544410 were significantly associated with childhood ASD [25]. Others reported an association between the VDR gene polymorphisms and the risk of ASD [37–39].

Lower levels of serum vitamin D in patients with ASD have been reported previous studies. A study determined serum levels of vitamins and minerals in 274 Chinese children diagnosed with ASD and 97 age-matched healthy children from the Han population from another Chinese region. Serum levels of vitamin D, calcium, magnesium, iron, and zinc in children with ASD were significantly lower than those of healthy controls [14]. Another Chinese study examined the serum vitamin D levels in 215 children with ASD and 285 healthy control children. Their study revealed that serum vitamin D concentrations were negatively correlated with ABC total scores and language subscale scores [40]. Other studies from various countries have indicated lower serum vitamin D in patients with ASD [10–13, 15, 41, 42]. This study corroborated that children with ASD had lower serum vitamin D and a higher prevalence rate of vitamin D deficiency. Consistently, several clinical trials showed the efficacy of vitamin D supplementation in the improvement of symptoms of ASD [12, 40, 43]. However, several other studies with smaller sample sizes reported no significant difference in serum vitamin D between children with ASD and healthy controls [27–29, 44].

Our study also found that serum vitamin D had a fair performance in distinguishing children with ASD from healthy controls with the area under the ROC curve of 0.7285. VDR SNPs did not further improve performance of serum vitamin D in predicting the risk of ASD. However, our results indicate that T/C genotype of rs731236 and deficiency of vitamin D indicated the highest risk of childhood ASD compared with another genotype with or without vitamin D deficiency. Since serum vitamin D can be measured at any time, it has the potential to become a marker in diagnosing ASD at younger ages. It is of clinical significance to identify other biomarkers which improve its predicting performance in the future studies.

Limitations of this study include a non-random selection of cases and controls. Only children with ASD treated in our hospitals were enrolled in this study. The sample size is still relatively moderate. Serum levels of vitamin D were measured only at the baseline. Information regarding dietary intake of vitamin D and sunlight exposure time were not recorded in these subjects. The cause of low serum vitamin D was therefore not able to be assessed in this study.

All examined common VDR SNPs are not correlated with serum vitamin D concentrations or vitamin D deficiency. The combination of T/C phenotype of rs731236 and vitamin D deficiency are associated with a higher risk of childhood ASD. Vitamin D is a promising target in the prevention and treatment of this disease.

ASD, Autism Spectrum Disorder; VDR, vitamin D receptor; ROC, receiver operating characteristic.

Acknowledgments

This work was supported by grants from Health commission of Zhejiang Province (2019KY151), Science Technology Department of Zhejiang Province (LY18H310009 and LGF19H09004) and Xiaoshan District Science and Technology Bureau of Hangzhou City (2018220).

Conflicts of Interest

The authors have declared no conflicts of interests with respect to the research, authorship, and/or publication of this article.

Author Contributions

Jun Liu and Zengyu Zhang attributed to conception and design. Material preparation, data collection and analysis were performed by Zengyu Zhang, Guojun Jiang, Hong Yu and Jung Liu. The first draft of the manuscript was written by Jun Liu and all authors commented on previous versions of the manuscript. All authors have read and approved the final manuscript.

Ethics Approval

This study was approved by the Medical Ethics Committee of Zhejiang Xiaoshan Hospital.

Consent to participate

Written informed consent was obtained from the parents.

Vijayakumar NT, Judy MV (2016) Autism spectrum disorders: Integration of the genome, transcriptome and the environment. J Neurol Sci 364:167–176. doi: 10.1016/j.jns.2016.03.026
Homberg JR, Kyzar EJ, Scattoni ML, Norton WH, Pittman J, Gaikwad S et al (2016) Genetic and environmental modulation of neurodevelopmental disorders: Translational insights from labs to beds. Brain Res Bull 125:79–91. doi: 10.1016/j.brainresbull.2016.04.015
Modabbernia A, Velthorst E, Reichenberg A (2017) Environmental risk factors for autism: an evidence-based review of systematic reviews and meta-analyses. Mol autism 8:13. doi: 10.1186/s13229-017-0121-4
Zhou H, Xu X, Yan W, Zou X, Wu L, Luo X et al (2020) Prevalence of Autism Spectrum Disorder in China: A Nationwide Multi-center Population-based Study Among Children Aged 6 to 12 Years. Neurosci Bull 36(9):961–971. doi: 10.1007/s12264-020-00530-6
Maenner MJ, Shaw KA, Baio J, EdS, Washington A, Patrick M et al (2020) Morbidity and mortality weekly report Surveillance summaries. 69:1–12. 10.15585/mmwr.ss6904a1. Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 20164
Bougeard C, Picarel-Blanchot F, Schmid R, Campbell R, Buitelaar J (2021) Prevalence of Autism Spectrum Disorder and Co-morbidities in Children and Adolescents: A Systematic Literature Review. Front Psychiatry 12:744709. doi: 10.3389/fpsyt.2021.744709
Maruotti N, Cantatore FP (2010) Vitamin D and the immune system. J Rhuematol 37(3):491–495. doi: 10.3899/jrheum.090797
Harms LR, Burne TH, Eyles DW, McGrath JJ (2011) Vitamin D and the brain. Best practice & research Clinical endocrinology. & metabolism 25(4):657–669. doi: 10.1016/j.beem.2011.05.009
Kocovska E, Gaughran F, Krivoy A, Meier UC (2017) Vitamin-D Deficiency As a Potential Environmental Risk Factor in Multiple Sclerosis, Schizophrenia, and Autism. Front Psychiatry 8:47. doi: 10.3389/fpsyt.2017.00047
Kocovska E, Andorsdottir G, Weihe P, Halling J, Fernell E, Stora T et al (2014) Vitamin d in the general population of young adults with autism in the faroe islands. J Autism Dev Disord 44(12):2996–3005. doi: 10.1007/s10803-014-2155-1
Bener A, Khattab AO, Al-Dabbagh MM (2014) Is high prevalence of Vitamin D deficiency evidence for autism disorder?: In a highly endogamous population. J Pediatr neurosciences 9(3):227–233. doi: 10.4103/1817-1745.147574
Saad K, Abdel-Rahman AA, Elserogy YM, Al-Atram AA, Cannell JJ, Bjorklund G et al (2016) Vitamin D status in autism spectrum disorders and the efficacy of vitamin D supplementation in autistic children. Nutr Neurosci 19(8):346–351. doi: 10.1179/1476830515Y.0000000019
Arastoo AA, Khojastehkia H, Rahimi Z, Khafaie MA, Hosseini SA, Mansouri MT et al (2018) Evaluation of serum 25-Hydroxy vitamin D levels in children with autism Spectrum disorder. Ital J Pediatr 44(1):150. doi: 10.1186/s13052-018-0587-5
Guo M, Li L, Zhang Q, Chen L, Dai Y, Liu L et al (2018) Vitamin and mineral status of children with autism spectrum disorder in Hainan Province of China: associations with symptoms. Nutr Neurosci 1–8. doi: 10.1080/1028415X.2018.1558762
Fernell E, Bejerot S, Westerlund J, Miniscalco C, Simila H, Eyles D et al (2015) Autism spectrum disorder and low vitamin D at birth: a sibling control study. Mol autism 6:3. doi: 10.1186/2040-2392-6-3
Chen J, Xin K, Wei J, Zhang K, Xiao H (2016) Lower maternal serum 25(OH) D in first trimester associated with higher autism risk in Chinese offspring. J Psychosom Res 89:98–101. doi: 10.1016/j.jpsychores.2016.08.013
Lee BK, Eyles DW, Magnusson C, Newschaffer CJ, McGrath JJ, Kvaskoff D et al (2019) Developmental vitamin D and autism spectrum disorders: findings from the Stockholm Youth Cohort. Mol Psychiatry 26:1578–1588. doi: 10.1038/s41380-019-0578-y
Levenson CW, Figueiroa SM (2008) Gestational vitamin D deficiency: long-term effects on the brain. Nutr Rev 66(12):726–729. doi: 10.1111/j.1753-4887.2008.00122.x
Eyles DW, Feron F, Cui X, Kesby JP, Harms LH, Ko P et al (2009) Developmental vitamin D deficiency causes abnormal brain development. Psychoneuroendocrinology 34(Suppl 1):S247–S257. doi: 10.1016/j.psyneuen.2009.04.015
Zmuda JM, Cauley JA, Ferrell RE (2000) Molecular epidemiology of vitamin D receptor gene variants. Epidemiol Rev 22(2):203–217
Saijo T, Ito M, Takeda E, Huq AH, Naito E, Yokota I et al (1991) A unique mutation in the vitamin D receptor gene in three Japanese patients with vitamin D-dependent rickets type II: utility of single-strand conformation polymorphism analysis for heterozygous carrier detection. Am J Hum Genet 49(3):668–673
Decker CJ, Parker R (1995) Diversity of cytoplasmic functions for the 3' untranslated region of eukaryotic transcripts. Curr Opin Cell Biol 7(3):386–392
Yamamoto H, Miyamoto K, Li B, Taketani Y, Kitano M, Inoue Y et al (1999) The caudal-related homeodomain protein Cdx-2 regulates vitamin D receptor gene expression in the small intestine. J bone mineral research: official J Am Soc Bone Mineral Res 14(2):240–247. doi: 10.1359/jbmr.1999.14.2.240
Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP (2004) Genetics and biology of vitamin D receptor polymorphisms. Gene 338(2):143–156. doi: 10.1016/j.gene.2004.05.014
Coskun S, Simsek S, Camkurt MA, Cim A, Celik SB (2016) Association of polymorphisms in the vitamin D receptor gene and serum 25-hydroxyvitamin D levels in children with autism spectrum disorder. Gene 588(2):109–114. doi: 10.1016/j.gene.2016.05.004
Zhang Z, Li S, Yu L, Liu J (2018) Polymorphisms in Vitamin D Receptor Genes in Association with Childhood Autism Spectrum Disorder. Dis Markers 2018:7862892. doi: 10.1155/2018/7862892
Molloy CA, Kalkwarf HJ, Manning-Courtney P, Mills JL, Hediger ML (2010) Plasma 25(OH)D concentration in children with autism spectrum disorder. Dev Med Child Neurol 52(10):969–971. doi: 10.1111/j.1469-8749.2010.03704.x
Uğur Ç, Gürkan CK (2014) Serum vitamin D and folate levels in children with autism spectrum disorders. Res Autism Spectr Disorders 8(12):1641–1647
Esparham AE, Smith T, Belmont JM, Haden M, Wagner LE, Evans RG et al (2015) Nutritional and Metabolic Biomarkers in Autism Spectrum Disorders: An Exploratory Study. Integr Med 14(2):40–53
Smolders J, Damoiseaux J, Menheere P, Tervaert JW, Hupperts R (2009) Fok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosis. J Neuroimmunol 207(1–2):117–121. doi: 10.1016/j.jneuroim.2008.12.011
Hossein-Nezhad A, Eshaghi SM, Maghbooli Z, Mirzaei K, Shirzad M, Curletto B et al (2014) The role of vitamin D deficiency and vitamin d receptor genotypes on the degree of collateralization in patients with suspected coronary artery disease. Biomed Res Int 2014:304250. doi: 10.1155/2014/304250
Agnello L, Scazzone C, Ragonese P, Salemi G, Lo Sasso B, Schillaci R et al (2016) Vitamin D receptor polymorphisms and 25-hydroxyvitamin D in a group of Sicilian multiple sclerosis patients. Neurol sciences: official J Italian Neurol Soc Italian Soc Clin Neurophysiol 37(2):261–267. doi: 10.1007/s10072-015-2401-0
Cieslinska A, Kostyra E, Chwala B, Moszynska-Dumara M, Fiedorowicz E, Teodorowicz M et al (2017) Vitamin D Receptor Gene Polymorphisms Associated with Childhood Autism. Brain Sci 7(9). doi: 10.3390/brainsci7090115
Wang D, Su K, Ding Z, Zhang Z, Wang C (2021) Association of Vitamin D Receptor Gene Polymorphisms with Metabolic Syndrome in Chinese Children. Int J Gen Med 14:57–66. doi: 10.2147/IJGM.S287205
Yu H, Liu J, Yang A, Yang G, Yang W, Lei H et al (2016) Lack of Association Between Polymorphisms in Dopa Decarboxylase and Dopamine Receptor-1 Genes With Childhood Autism in Chinese Han Population. J Child Neurol 31(5):560–564. doi: 10.1177/0883073815601496
Rivera-Paredez B, Macias N, Martinez-Aguilar MM, Hidalgo-Bravo A, Flores M, Quezada-Sanchez AD et al (2018) Association between Vitamin D Deficiency and Single Nucleotide Polymorphisms in the Vitamin D Receptor and GC Genes and Analysis of Their Distribution in Mexican Postmenopausal Women. Nutrients 10(9). doi: 10.3390/nu10091175
Schmidt RJ, Hansen RL, Hartiala J, Allayee H, Sconberg JL, Schmidt LC et al (2015) Selected vitamin D metabolic gene variants and risk for autism spectrum disorder in the CHARGE Study. Early Hum Dev 91(8):483–489. doi: 10.1016/j.earlhumdev.2015.05.008
Guerini FR, Bolognesi E, Chiappedi M, Mensi MM, Fumagalli O, Rogantini C et al (2020) Vitamin D Receptor Polymorphisms Associated with Autism Spectrum Disorder. Autism research: official journal of the International Society for Autism Research 13(5):680–690. doi: 10.1002/aur.2279
Yang H, Wu X (2020) The Correlation Between Vitamin D Receptor (VDR) Gene Polymorphisms and Autism: A Meta-analysis. J Mol neuroscience: MN 70(2):260–268. doi: 10.1007/s12031-019-01464-z
Feng J, Shan L, Du L, Wang B, Li H, Wang W et al (2017) Clinical improvement following vitamin D3 supplementation in Autism Spectrum Disorder. Nutr Neurosci 20(5):284–290. doi: 10.1080/1028415X.2015.1123847
Altun H, Kurutas EB, Sahin N, Gungor O, Findikli E, Vitamin D, Receptor D (2018) Homocysteine and Complex B Vitamin in Children with Autism Spectrum Disorders. Clinical psychopharmacology and neuroscience: the official scientific journal of the Korean College of Neuropsychopharmacology. ;16(4):383 – 90. doi: 10.9758/cpn.2018.16.4.383
Mostafa GA, Al-Ayadhi LY (2012) Reduced serum concentrations of 25-hydroxy vitamin D in children with autism: relation to autoimmunity. J Neuroinflamm 9:201. doi: 10.1186/1742-2094-9-201
Stubbs G, Henley K, Green J, Autism (2016) Will vitamin D supplementation during pregnancy and early childhood reduce the recurrence rate of autism in newborn siblings? Med Hypotheses 88:74–78. doi: 10.1016/j.mehy.2016.01.015
Hashemzadeh M, Moharreri F, Soltanifar A (2015) Comparative study of vitamin D levels in children with autism spectrum disorder and normal children: a case-control study. J Fundamentals Mental Health 17(4):197–201

Supplementaldata.docx

Download PDF

Reviewers agreed at journal
09 Jun, 2022
Reviewers invited by journal
09 Jun, 2022
Editor assigned by journal
08 Jun, 2022
First submitted to journal
07 Jun, 2022

You are reading this latest preprint version

Vitamin D receptor gene variants and serum vitamin D in Childhood Autism Spectrum Disorder

Status:

Version 1

Abstract

Figures

Introduction

Patients And Methods

Statistical analysis

Results

Discussion

Conclusions

Abbreviations

Declarations

References

Supplementary Files

Status:

Version 1